Last update Aug. 23, 2021

Nostrilla™

Low Risk

Moderately safe. Probably compatible. Mild risk possible. Follow up recommended. Read the Comment.

Nostrilla is a tradename that contains a main active ingredient in its composition:

For more information (pharmacokinetics, references, ...) tap the name of the active ingredient.

Note: The composition of certain tradenames varies in each country. Please, make sure this is the composition of the tradename you are looking for..

Alternatives

  • Azelastine (Moderately safe. Probably compatible. Mild risk possible. Follow up recommended. Read the Comment.)
  • Budesonide ( Safe. Compatible. Minimal risk for breastfeeding and infant.)
  • Fluticasone ( Safe. Compatible. Minimal risk for breastfeeding and infant.)
  • Mometasone Furoate ( Safe. Compatible. Minimal risk for breastfeeding and infant.)
  • Sodium Chloride ( Safe. Compatible. Minimal risk for breastfeeding and infant.)
  • Sodium Cromoglicate ( Safe. Compatible. Minimal risk for breastfeeding and infant.)

Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Total visits

2,909

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at elactancia.org@gmail.com

e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2015 of United States of America

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM